Chemical Compound

Retigabine

CAS Registry Number 150812-12-7
Retigabine chemical structure
Primary Record

Retigabine

In stock
1,744 g
Purity
99.6 %
CAS
150812-12-7

Compound Identifiers & Properties

CAS
150812-12-7
PubChem CID
121892
SMILES
CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N
Canonical SMILES
CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N

Names & Synonyms

  • Retigabine
  • Ezogabine
  • Potiga
  • Trobalt
  • 150812-12-7
  • Retigabina
  • Potiva
  • retigabinum
  • Retigabin
  • Ezogabine [USAN]
  • Retigabine?
  • Retigabine [USAN]
  • Retigabine [INN]
  • Retigabine Dihydrochloride
  • Retigabine (INN)
  • Ezogabine (USAN)
  • Potiga (TN)
  • GKE-841
  • D-23129
  • EZOGABINE [MI]
  • AC1L3TLD
  • RefChem:139807
  • 12G01I6BBU
  • EZOGABINE [VANDF]
  • UNII-12G01I6BBU
  • XEN496
  • WAY-143841
  • Retigabine-d4 Dihydrochloride
  • C16H18FN3O2
  • CHEMBL41355
  • D0X7GL
  • RETIGABINE [MART.]
  • XEN-496
  • RETIGABINE [WHO-DD]
  • AWD-21360
  • AWD21-360
  • GW582892X
  • SCHEMBL20835
  • cc-439
  • CHEBI:68584
  • HSDB 8171
  • orb146123
  • GW-582892X
  • RETIGABINE [EMA EPAR]
  • DTXSID40164615
  • GKI 841
  • N03AX21
  • Retigabine, analytical standard
  • GTPL2601
  • DEA No. 2779
  • EZOGABINE [ORANGE BOOK]
  • DTXCID5087106
  • GW 582892X
  • Retigabine, >=98% (HPLC)
  • SCHEMBL29359156
  • WAY 143841
  • CTK8E8130
  • ZINC16154
  • Ethyl 2-amino-4-((p-fluorobenzyl)amino)carbanilate
  • PCOBBVZJEWWZFR-UHFFFAOYSA-N
  • GLXC-05007
  • HMS3748I09
  • HMS3885L20
  • HMS5083I22
  • Retigabine (1.0 mg/mL in Acetonitrile)
  • ADD-230001
  • AMY18466
  • BCP04194
  • EX-A2203
  • KBC88670
  • KE-0201
  • KS-000007VJ
  • Retigabine,D2312, D-23129
  • BDBM50143558
  • C16-H18-F-N3-O2
  • CID121892
  • KE 841
  • MFCD04307735
  • N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester
  • s4733
  • ZINC00016154
  • ethyl N-[2-amino-4-[(4-fluorophenyl)methylamino]phenyl]carbamate
  • AKOS015895311
  • D 20443
  • D 23129
  • D-20443
  • Retigabine Dihydrochloride Impurity 17
  • AC-6908
  • AN-6616
  • CCG-267503
  • CS-0990
  • CS-O-02282
  • DB04953
  • FA61501
  • QC-1587
  • RL01925
  • NCGC00346739-01
  • NCGC00346739-05
  • NCGC00346739-06
  • AJ-08384
  • AW21-360
  • BC210476
  • HY-15471
  • LS-48932
  • SC-23393
  • ZB000739
  • BCP0726000089
  • AB0035830
  • ethyl (2-amino-4-((4-fluorobenzyl)amino)phenyl)carbamate
  • J751.646K
  • N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester
  • RT-015392
  • 2632B
  • AE3 - Newer Anti-epileptic drug mixtures 3
  • B5888
  • Ethyl (2-amino-4-(((4-fluorophenyl)methyl)amino)phenyl)carbamate
  • NS00040686
  • RetigabineSee also: R189051 (HCl salt)
  • TL80090034
  • Y0237
  • A11922
  • C13826
  • D09569
  • D23129
  • Ethyl [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]carbamate
  • ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate
  • S-7700
  • 812R127
  • A809076
  • 2-AMINO-4-(4-FLUORBENZYLAMINO)-1-ETHOXYCARBONYLAMINOBENZENE
  • Carbamic acid, (2-amino-4-(((4-fluorophenyl)methyl)amino)phenyl)-, ethyl ester
  • ethyl N-[2-azanyl-4-[(4-fluorophenyl)methylamino]phenyl]carbamate
  • I06-0810
  • Q2146170
  • [2-Amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-carbamate
  • BRD-K89917372-001-01-2
  • ethyl 2-amino-4-(4-fluorobenzylamino)phenylcarbamate
  • 150812-13-8
  • N-(2-amino-4-[fluorobenzylamino]-phenyl) carbamic acid|D-23129
  • ethyl N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamate hydrochloride
  • ethyl N-(2-amino-4-{[(4-fluorophenyl)methyl]amino}phenyl)carbamate
  • (1R,3S)-3-(tert-Butoxycarbonylamino)cyclohexanecarboxylic Acid
  • 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonylaminobenzene
  • Ethyl (2-amino-4-{[(4-fluorophenyl)methyl]amino}phenyl)carbamate
  • ethyl N-(2-amino-4-((4-fluorophenyl)methylamino)phenyl)carbamate
  • N-(2-amino-4-(4-fluorobenzylamino)-phenyl)carbamic acid ethylester
  • n-[2-amino-4-(4-fluorobenzylamino)-phenyl]carbamic acid ethyl ester
  • n-[2-amino-4-(4-fluorobenzylamino)phenyl]carbamic acid ethyl ester
  • [2-Amino-4-(4-fluoro-benzylamino)-phenyl]-carbamic acid ethyl ester
  • 1285886-70-5
  • N-[2-Amino-4-[(4-fluorobenzyl)amino]phenyl]carbamic acid ethyl ester
  • N-[2-amino-4-[(4-fluorophenyl)methylamino]phenyl]carbamic acid ethyl ester
  • RTG
  • 1,1,2,2,2-pentadeuterioethyl N-[2-amino-4-[(4-fluorophenyl)methylamino]phenyl]carbamate
  • CARBAMIC ACID, (2-AMINO-4-(((4-FLUORO-PHENYL)METHYL)AMINO)PHENYL)-ETHYL ESTER
  • N-[2-Amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]carbamic acid ethyl ester
  • Carbamic acid, N-[2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-, ethyl ester; Carbamic acid, [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-, ethyl ester (9CI); D 23129; Ethyl [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]carbamate; Ezogabine; GKE 841; GW 582892X; Potiga; Retigabine; Trobalt; WAY 143841; GW 582892X; Ezogabine
  • EZG
  • FBX
  • Retigabine solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material